Found: 7
Select item for more details and to access through your institution.
Venous thrombotic events and impact on outcomes in patients treated with first-line single-agent pembrolizumab in PD-L1 ≥ 50% advanced non small cell lung cancer.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2023, v. 149, n. 16, p. 15095, doi. 10.1007/s00432-023-05321-w
- By:
- Publication type:
- Article
Paclitaxel–bevacizumab combination in advanced non-squamous non-small-cell lung cancer (NSCLC): AVATAX, a retrospective multicentric study.
- Published in:
- Therapeutic Advances in Medical Oncology, 2022, p. 1, doi. 10.1177/17588359221099399
- By:
- Publication type:
- Article
A Rare Fusion of CLIP1 and ALK in a Case of Non-Small-Cell Lung Cancer With Neuroendocrine Features.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Unusually prolonged pemetrexed cytotoxicity in a patient with a lung adenocarcinoma: a case report.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Partial response of pulmonary adenocarcinoma with symptomatic brain metastasis to nivolumab plus high-dose oral corticosteroid: a case report.
- Published in:
- 2017
- By:
- Publication type:
- journal article
First-line single-agent pembrolizumab for PD-L1-positive (tumor proportion score ≥ 50%) advanced non-small cell lung cancer in the real world: impact in brain metastasis: a national French multicentric cohort (ESCKEYP GFPC study).
- Published in:
- Cancer Immunology, Immunotherapy, 2023, v. 72, n. 1, p. 91, doi. 10.1007/s00262-022-03232-2
- By:
- Publication type:
- Article
Pharmacokinetic herb‐drug interaction between ginger and crizotinib.
- Published in:
- British Journal of Clinical Pharmacology, 2020, v. 86, n. 9, p. 1892, doi. 10.1111/bcp.13862
- By:
- Publication type:
- Article